• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 5 of 35
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
HealthRSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
By Lindsey LeakeOctober 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
HealthCOVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
COVIDtests.gov will once again offer each U.S. household four free COVID-19 test kits beginning in late September 2024.
HealthFree, at-home COVID tests are back. Here’s how to order yours
By Lindsey LeakeSeptember 24, 2024
Fall begins Sept. 22 and with the change of seasons, the new XEC COVID subvariant that started circulating in Europe over the summer has made its way to the U.S.
HealthWill the XEC COVID variant bring a fall wave of infections? What to know about symptoms and spread
By Lindsey LeakeSeptember 18, 2024
NewslettersMedical AI could be great. But the way we are regulating it now is dangerous
By Jeremy KahnSeptember 17, 2024
TechApple gets green light from FDA to add feature that will let AirPods Pro 2 be used as hearing aids
By Glenn Chapman and AFPSeptember 13, 2024
HealthThousands of drug plants have gone uninspected by the FDA since 2019
By Matthew Perrone, Nicky Forster and The Associated PressSeptember 6, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
New COVID vaccine in its box
HealthFDA approves updated COVID-19 vaccines, shots should be available in days
By The Associated Press and Lauran NeergaardAugust 22, 2024
MeAgainMeds.com, a free tool developed by researchers at the George Mason University College of Public Health in Fairfax, Va., uses AI to pair people with depression with the best available antidepressant medication for them.
MindAntidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By Lindsey LeakeAugust 14, 2024
FDA sign
HealthFDA rejects psychedelic drug MDMA as a treatment for PTSD
By Matthew Perrone and The Associated PressAugust 10, 2024
Casey Tylek
HealthVeterans with PTSD are pushing for psychedelic drug therapy
By Matthew Perrone and The Associated PressJuly 26, 2024
several colorful packages of Diamond Shruumz products on orange background
Health‘Brain health’ mushroom gummies with illegal hallucinogens have sent over 70 to ER
By Beth GreenfieldJuly 18, 2024
Obesity medicine physician Dr. Nisha Patel breaks down five weight loss myths that “need to die” with Fortune.
HealthThe 5 biggest weight loss myths that ‘need to die,’ according to an obesity doctor
By Lindsey LeakeJuly 18, 2024
HealthWhat are the symptoms of bird flu and how does it spread?
By Lindsey LeakeJuly 15, 2024
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...35
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.